Unlike traditional clinical scales such as NIHSS, which mainly assess neurological severity, or inflammatory biomarkers like CRP, the WBC/HDL ratio integrates both inflammatory and lipid metabolic pathways, offering complementary information that can enhance stroke prognosis prediction. Here, CRP is linked to stroke disorder.